efectos secundarios de tirzepatide Tirzepatida: usos, secundarios, dosis e interacciones La importancia de la dieta

The fact that you are reading about it here means you're doing your due diligence the right way

This novel mechanism enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite, making it effective for glycemic control and weight reduction

Side effects cluster in the first 72 hours after each weekly injection and in the first 2 to 4 weeks of every dose escalation

Compounded tirzepatide is not FDA-approved and, when prescribed, is prepared by licensed 503A compounding pharmacies for eligible patients

Tirzepatide holds FDA approvals as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023) and for moderate-to-severe obstructive sleep apnea (2024), and it is EMA-approved as well

Either way, discard the vial immediately